Jean-Jacques Mourad: Cohort Study Insights on Aspirin Use in Patients with Horton’s Disease
Jean-Jacques Mourad, Head of Internal Medicine at Franco-British Hospital, shared a post on LinkedIn about a recent article by Maxime Beydon, published in JAMA Network Open, adding:
“When well-constructed and properly analyzed cohort studies provide answers to the gray areas left by randomized trials…
All my sincere congratulations to the French authors of this work, which allows us to weigh a little more clearly the pros and cons of aspirin in patients treated for a Horton’s.”
Title: Low-Dose Aspirin for Cardiovascular Disease Primary Prevention in Patients With Giant Cell Arteritis
Authors: Maxime Beydon, David Hajage, Alexis F. Guédon, Fabrice Carrat, Raphaèle Seror, Florence Tubach
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 8, 2026, 14:13Harshal Kale: From Personal Journey to Global Advocacy
-
Jun 8, 2026, 14:11Aryabhatta Sadhu: Evidence-Based Restrictive Transfusion and Patient Blood Management
-
Jun 8, 2026, 14:05Burhan Ullah: The Expanding Role of Hematology Analyzers in Disease Detection and Monitoring
-
Jun 8, 2026, 13:502025 EHA Annual Report Is Now Online
-
Jun 8, 2026, 13:49Lovish Garg: Advances in Endovascular Treatment for Deep Vein Thrombosis
-
Jun 8, 2026, 13:39Tasbeeh Ahmed: Contemporary Treatment Strategies for Chronic Venous Disease
-
Jun 8, 2026, 13:35Wolfgang Miesbach: Translating Gene Therapy into Haemophilia Care at EHA 2026
-
Jun 8, 2026, 13:27Emile Hung: Why Nutrition Should Be Central to Vascular Disease Prevention
-
Jun 8, 2026, 12:21William Aird: Developing Patient-Facing Educational Material for The Blood Project